Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19
Condition: Covid19 Interventions: Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector); Biological: Placebo Sponsors: NPO Petrovax; CanSino Biologics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials